<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1834">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383587</url>
  </required_header>
  <id_info>
    <org_study_id>20-004054</org_study_id>
    <nct_id>NCT04383587</nct_id>
  </id_info>
  <brief_title>Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers</brief_title>
  <official_title>Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify healthcare workers with SARS CoV 2 antibodies who
      have not been previously diagnosed and are presumed COVID-19 negative, then determine the
      level of immunity in this population which could inform further decisions about widespread
      antibody testing in a healthcare worker population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled participants will complete a survey gauging their level of confidence they will be
      antibody positive. Participants will then complete serologic testing for SARS CoV 2 IgG
      antibodies. The study will characterize the prevalence of antibody positivity in this
      population and assess whether there is a correlation between a pre-test confidence level
      using a Likert scale and actual antibody positivity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 6, 2020</start_date>
  <completion_date type="Actual">July 31, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of COVID19 Antibody Positivity</measure>
    <time_frame>1 month</time_frame>
    <description>Presence of IgG antibodies detected</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability to predict immune status/antibody positivity</measure>
    <time_frame>1 month</time_frame>
    <description>Survey of participants to gauge their confidence they will be antibody positive</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>SARS-CoV 2</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Serologic Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Enrolled participants will have COVID19 IgG antibody testing performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serologic testing</intervention_name>
    <description>COVID19 IgG antibody testing to be performed</description>
    <arm_group_label>Serologic Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years old.

          -  Mayo Clinic employee in procedural and surgical area.

          -  Suspected COVID-19 exposure.

          -  Completed PCR test twice with negative results.

        Exclusion Criteria:

        - Refusal to participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Parkulo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Mark A. Parkulo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

